If you or a loved one suffered a heart attack, stroke or pulmonary embolism after using testosterone replacement therapy such as AndroGel®, you may be eligible for compensation for your injuries.
Contact the drug injury lawyers at Cory Watson Attorneys today for a free evaluation of your case. Your call and initial case review are free, and we can help determine if testosterone replacement therapy may have been responsible for you or your loved one’s injuries or death. Call (877) 562-0000 or complete our free initial consultation form now.
FDA Requires Testosterone Therapy Supplements to Update Warning Labels
The U.S. Food and Drug Administration (FDA) is requiring manufacturers of all approved prescription testosterone products to clarify the approved uses of these medications on product labeling. The FDA is also requiring these manufacturers to add information to the labeling about a possible risk of heart attacks and strokes in patients taking testosterone.
FDA officials caution that prescription testosterone products are approved only for men who have low testosterone levels caused by certain medical conditions. The benefit and safety of these medications has not been established for treatment of low testosterone levels due to aging.
Our Testosterone Drug Injury Lawyers Can Help You
Testosterone drugs like AndroGel have been linked to serious injuries, such as heart attack, stroke, and pulmonary embolism. The drugs were approved by the U.S. Food & Drug Administration (FDA) for conditions associated with:
- Deficiency or absence of endogenous (naturally produced by the body) testosterone
- Primary hypogonadism
- Hypogonadotropic hypogonadism
Millions of dollars were spent by pharmaceutical companies urging men to talk to their doctors about low testosterone or “Low T” if they suffer decreased sexual desire, erectile dysfunction, fatigue, or depression.
Testosterone Therapy Can Be Deadly
On January 31, 2014, the FDA announced they were investigating an increased risk of heart attack, stroke and cardiac death related to testosterone replacement therapy use. Men using testosterone replacement therapy drugs are at risk and could experience serious side effects, including heart attack, stroke and pulmonary embolism.
Low T Drugs That May Put Men at Risk
The following Testosterone brands may increase the risk of heart attack, stroke or pulmonary embolism:
The Dangers of Testosterone Replacement Therapy
Emerging research shows that testosterone replacement therapy may cause debilitating side effects, such as heart attack, stroke or pulmonary embolism. A peer-reviewed study showed that men who underwent testosterone replacement therapy could seriously increase their chances of heart attack or other cardiovascular issues.
Testosterone Replacement Therapy is approved by the FDA to treat conditions associated with a deficiency or absence of endogenous testosterone, primacy hypogonadism, and hypogonadotropic hypogonadism.
Recent studies show that an estimated four percent of all men over 60 years old have used testosterone replacement therapy. While testosterone treatments are approved by the FDA for use in men with a deficiency or absence of testosterone, a study published in 2013 showed that nearly a quarter of men prescribed testosterone treatments had never had their testosterone levels checked.
Companies that manufacture testosterone treatments have marketed the drugs as a cure for low testosterone or “Low T.” Drug manufacturers have made claims that restoring levels of testosterone using their products can improve quality of life and cure memory loss and erectile dysfunction.
Find Out If You Have a Testosterone Therapy Lawsuit
If you or someone you love suffered a heart attack, stroke or pulmonary embolism after using a Low T drug, contact the drug injury lawyers at Cory Watson Attorneys today for a free evaluation of your case. Based in Birmingham, Alabama, our nationally respected lawyers have recovered more than $2.7 billion for clients across the United States, and we want to help. Call (877) 562-0000 or complete a free initial consultation form to get started.
Cory Watson Attorneys is not associated with, sponsored by or affiliated with The U.S. Food and Drug Administration, AbbVie, USA Today, The New England Journal of Medicine, PLOS One, or JAMA Internal Medicine.
AndroGel is a registered trademark of AbbVie and is used here only to identify the product in question. Androderm is a registered trademark of Watson and is used here only to identify the product in question. Axiron is a registered trademark of Eli Lilly and Co. and is used here only to identify the product in question. Fortesta is a registered trademark of Endo Pharmaceuticals and is used here only to identify the product in question. Testim is a registered trademark of Auxilium Pharmaceuticals Inc. and is only used here to identify the product in question.